|
1
|
Principe DR, Kamath SD, Korc M and Munshi
HG: The immune modifying effects of chemotherapy and advances in
Chemo-immunotherapy. Pharmacol Ther. 236:1081112022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yusuf K, Sampath V and Umar S: Bacterial
infections and cancer: Exploring this association and its
implications for patients with cancer. Int J Mol Sci. 24:31102023.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Terrones-Campos C, Ledergerber B, Specht
L, Vogelius IR, Helleberg M and Lundgren J: Risk of bacterial,
viral, and fungal infections in patients with solid malignant
tumors treated with curative intent radiation therapy. Adv Radiat
Oncol. 7:1009502022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Goswami M, Prince G, Biancotto A, Moir S,
Kardava L, Santich BH, Cheung F, Kotliarov Y, Chen J, Shi R, et al:
Impaired B-cell immunity in patients with acute myeloid leukemia
after chemotherapy. J Transl Med. 15:1552017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zandvoort A, Lodewijk ME, Klok PA, Dammers
PM, Kroese FG and Timens W: Slow recovery of follicular B cells and
marginal zone B cells after chemotherapy: Implications for humoral
immunity. Clin Exp Immunol. 124:172–179. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Henderson DK, Dembry LM, Sifri CD, Palmore
TN, Dellinger EP, Yokoe DS, Grady C, Heller T, Weber D, Del Rio C,
et al: Management of healthcare personnel living with hepatitis B,
hepatitis C, or human immunodeficiency virus in US healthcare
institutions. Infect Control Hosp Epidemiol. 43:147–155. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Uyeki TM, Bernstein HH, Bradley JS,
Englund JA, File TM, Fry AM, Gravenstein S, Hayden FG, Harper SA,
Hirshon JM, et al: Clinical practice guidelines by the infectious
diseases society of America: 2018 update on diagnosis, treatment,
chemoprophylaxis, and institutional break management of seasonal
influenza. Clin Infect Dis. 68:e1–e47. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lv M, Liu Y, Liu W, Xing Y and Zhang S:
Immunotherapy for pediatric acute lymphoblastic leukemia: Recent
advances and future perspectives. Front Immunol. 13:9218942022.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gavralidis A and Brunner AM: Novel
therapies for treating adult acute lymphoblastic leukemia. Curr
Hematol Malig Rep. 15:294–304. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sas V, Moisoiu V, Teodorescu P, Tranca S,
Pop L, Iluta S, Pasca S, Blag C, Man S, Roman A, et al: Approach to
the adult acute lymphoblastic leukemia patient. J Clin Med.
8:11752019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ghany MG, Feld JJ, Chang KM, Chan HLY, Lok
ASF, Visvanathan K and Janssen HLA: Serum alanine aminotransferase
flares in chronic hepatitis B infection: Good and bad. Lancet
Gastroenterol Hepatol. 5:406–417. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Terrault NA, Lok ASF, McMahon BJ, Chang
KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH and Wong JB: Update
on the prevention, diagnosis, and treatment of chronic hepatitis B:
AASLD 2018 hepatitis B guidance. Hepatology. 67:1560–1599. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang G and Duan Z: Guidelines for
prevention and treatment of chronic hepatitis B. J Clin Transl
Hepatol. 9:769–791. 2021.PubMed/NCBI
|
|
14
|
Campos-Valdez M, Monroy-Ramírez HC,
Armendáriz-Borunda J and Sánchez-Orozco LV: Molecular mechanisms
during hepatitis B infection and the effects of the virus
variability. Viruses. 13:11672021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kramvis A, Chang KM, Dandri M, Farci P,
Glebe D, Hu J, Janssen HLA, Lau DTY, Penicaud C, Pollicino T, et
al: A roadmap for serum biomarkers for hepatitis B virus: Current
status and future outlook. Nat Rev Gastroenterol Hepatol.
19:727–745. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saitta C, Pollicino T and Raimondo G:
Occult hepatitis B virus infection: An UPdate. Viruses.
14:15042022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cai Y and Yin W: Multiple functions of B
cells in chronic HBV infection. Front Immunol. 11:5822922020.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Heylmann D, Bauer M, Becker H, van Gool S,
Bacher N, Steinbrink K and Kaina B: Human CD4+CD25+ regulatory
T-cells are sensitive to Low-dose cyclophosphamide. PLoS One.
8:e833842013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Toksvang LN, Lee SHR, Yang JJ and
Schmiegelow K: Maintenance therapy for acute lymphoblastic
leukemia: Basic science and clinical translations. Leukemia.
36:1749–1758. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang H, Lu Y, Zhang Y, Dong J, Jiang S
and Tang Y: DHA-enriched phosphatidylserine ameliorates
cyclophosphamide-induced liver injury via regulating the gut-liver
axis. Int Immunopharmacol. 140:1128952024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Khimani F, Ranspach P, Elmariah H, Kim J,
Whiting J, Nishihori T, Locke FL, Perez Perez A, Dean E, Mishra A,
et al: Increased infections and delayed CD4+ T cell but Faster B
cell immune reconstitution after Post-transplantation
cyclophosphamide compared to conventional GVHD prophylaxis in
allogeneic transplantation. Transplant Cell Ther. 27:940–948. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kondĕlková K, Vokurková D, Krejsek J,
Borská L, Fiala Z and Ctirad A: Regulatory T cells (TREG) and their
roles in immune system with respect to immunopathological
disorders. Acta Medica (Hradec Kralove). 53:73–77. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Naicker SD, Feerick CL, Lynch K, Swan D,
McEllistrim C, Henderson R, Leonard NA, Treacy O, Natoni A, Rigalou
A, et al: Cyclophosphamide alters the tumor cell secretome to
potentiate the anti-myeloma activity of daratumumab through
augmentation of macrophage-mediated antibody dependent cellular
phagocytosis. Oncoimmunology. 10:18592632021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Scurr M, Pembroke T, Bloom A, Roberts D,
Thomson A, Smart K, Bridgeman H, Adams R, Brewster A, Jones R, et
al: Low-dose cyclophosphamide induces antitumor T-cell responses,
which associate with survival in metastatic colorectal cancer. Clin
Cancer Res. 23:6771–6780. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao L, Jiang Z, Jiang Y, Ma N, Wang K and
Zhang Y: Changes in immune cell frequencies after cyclophosphamide
or mycophenolate mofetil treatments in patients with systemic lupus
erythematosus. Clin Rheumatol. 31:951–959. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kaneno R, Shurin GV, Tourkova IL and
Shurin MR: Chemomodulation of human dendritic cell function by
antineoplastic agents at low non-cytotoxic concentrations. J Transl
Med. 7:582009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Byrd-Leifer CA, Block EF, Takeda K, Akira
S and Ding A: Role of MyD88 and TLR4 in LPS-mimetic activity of
Taxol. Eur J Immunol. 31:2448–2457. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
John J, Ismail M, Riley C, Askham J,
Morgan R, Melcher A and Pandha H: Differential effects of
paclitaxel on dendritic cell function. BMC Immunol. 11:142010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Noori M, Azizi S, Abbasi Varaki F,
Nejadghaderi SA and Bashash D: A systematic review and
meta-analysis of the immune response against the first and second
doses of SARS-CoV-2 vaccines in adult patients with hematological
malignancies. Int Immunopharmacol. 110:1090462022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rubio-Viqueira B, Jung KH, Rodriguez
Moreno JF, Grande E, Marrupe Gonzalez D, Lowndes S, Puente J,
Kristeleit H, Farrugia D, McNeil SA, et al: Immunogenicity and
safety of the adjuvanted recombinant zoster vaccine in patients
with solid tumors, vaccinated before or during chemotherapy: A
randomized trial. Cancer. 125:1301–1312. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pedrazzoli P, Lasagna A, Cassaniti I,
Ferrari A, Bergami F, Silvestris N, Sapuppo E, Di Maio M, Cinieri S
and Baldanti F: Vaccination for herpes zoster in patients with
solid tumors: A position paper on the behalf of the Associazione
Italiana di Oncologia Medica (AIOM). ESMO Open. 7:1005482022.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wei Z, He J, Wang C, Bao J, Leng T and
Chen F: Importance of booster vaccination in the context of Omicron
waves. Front Immunol. 13:9779722022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fendler A, de Vries EGE, Geurtsvan Kessel
CH, Haanen JB, Wörmann B, Turajlic S and von Lilienfeld-Toal M:
COVID-19 vaccines in patients with cancer: Immunogenicity,
efficacy, and safety. Nat Rev Clin Oncol. 19:385–401. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao L, Fu L, He Y, Li H, Song Y and Liu
S: Effectiveness and safety of COVID-19 vaccination in patients
with malignant disease. Vaccines (Basel). 11:4862023. View Article : Google Scholar : PubMed/NCBI
|
